Kahira Pharmaceuticals Restates FY Net Profit To EGP 552.5 Million
Kahira Pharmaceuticals And Chemical Industries restated its FY net profit after tax to EGP 552.5 million and FY sales to EGP 2.51 billion.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Kahira Pharmaceuticals restates FY net profit to EGP 552.5m
Company restates FY net profit to EGP 552.5 million.